Purchase Order 75N95023P00394

Award Date 6/27/23
Potential Completion Date 6/26/24
Potential Value $198K
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a purchase order awarded by the National Institutes of Health (NIH) National Institute on Aging to Quanterix Corporation, a for-profit life sciences company, for the delivery of Simoa 4-plex assay kits and related materials. The order is valued at $39,428.06 and is for the supply of Neurology 4-Plex E assay kits, Simoa disk kits, and buffer solutions to process tau protein (p-tau 181) assays for the Baltimore Longitudinal Study of Aging (BLSA). The order does not have a set-aside...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a for-profit manufacturer, for the purchase of Simoa 4-plex 96-well plate assays. The assays will be used to investigate biomarkers related to Alzheimer's disease as part of the Baltimore Longitudinal Study of Aging. The potential value of the award is $197,969.40, and the completion date is December 20, 2021. This...
This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $107,238.60 firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer, for Simoa 4-plex 96-well plate assays to quantify serum/plasma biomarkers for Alzheimer's disease research. The assays will be used to analyze samples from participants in the Baltimore Longitudinal Study of Aging and the Genetic and Epigenetic Signatures of Translational Aging Laboratory...
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $180,806 firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company that provides digital biomarker detection technology. The contract is for a SIMOA HD-X analyzer, which will replace the Institute's aging HD-1 platform and be used by the entire NIA Intramural Research Program. Quanterix has received over $30 million in prior federal contracts from...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $209,479.20 firm fixed-price purchase order to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract is for the delivery of assay kits. Quanterix has previously received over $30 million in federal contracts from agencies including the National Institutes of Health, Department of Veterans Affairs, and...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...

This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The order was issued on a sole source basis due to the need for scientific continuity in NIA's studies analyzing biomarkers for neurodegenerative diseases, which have previously utilized the specified Quanterix products. Performance will take place in Billerica, with delivery of the kits to NIA in Bethesda, Maryland by June 2024. There is no set-aside designation for this purchase.

Generated 12/15/23, 10:32 AM